[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 4 of about 4
1. Foley RJ, Metersky ML: Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration; 2008;75(2):211-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcoidosis is a systemic granulomatous disease of unknown etiology, in which the lungs and intrathoracic lymph nodes are predominant sites of involvement.
  • [MeSH-major] Antihypertensive Agents / therapeutic use. Endothelin-1 / antagonists & inhibitors. Hypertension, Pulmonary / drug therapy. Sarcoidosis, Pulmonary / complications. Sulfonamides / therapeutic use
  • [MeSH-minor] Hemodynamics / drug effects. Humans. Male. Middle Aged. Respiratory Function Tests


2. [EXPERIENCE WITH THE NEW SKIN TEST DIASKINTEST® USED TO DIAGNOSE RESPIRATORY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN A TUBERCULOSIS UNIT]. Tuberk Biolezni Legkih; 2010;(1):16-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seventy-two patients aged 4 to years, who had first detected X-ray changes in the lung or intrathoracic lymph nodes and had received no antituberculous drugs before study, were examined to estimate the sensitivity and specificity of the new skin test Diaskintest® (recombinant CFR-10--ESAT-6 protein produced by Escherichia coli BL21(DE3)/pCFP--ESAT).
  • The high sensitivity (96.2%) and specificity (84.6%) of the new skin test Diaskintest® permit its use in the comprehensive examination of patients with clinical and radiological signs in a specialized hospital, contributing to the shorter duration of differential diagnosis in difficult diagnostic cases.
  • [MeSH-major] Antigens, Bacterial. Bacterial Proteins. Immunologic Tests / methods. Mycobacterium tuberculosis / immunology. Tuberculin. Tuberculosis, Pulmonary
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Comparative Effectiveness Research. Female. Hospitals, Chronic Disease / statistics & numerical data. Humans. Indicators and Reagents / pharmacology. Male. Patient Acuity. Reproducibility of Results. Russia / epidemiology. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27529925.001).
  • [ISSN] 2075-1230
  • [Journal-full-title] Tuberkulëz i bolezni lëgkikh
  • [ISO-abbreviation] Tuberk Biolezni Legkih
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / CFP-10 protein, Mycobacterium tuberculosis; 0 / ESAT-6 protein, Mycobacterium tuberculosis; 0 / Indicators and Reagents; 0 / Tuberculin
  •  go-up   go-down


3. Suga K, Yuan Y, Ueda K, Kaneda Y, Kawakami Y, Zaki M, Matsunaga N: Computed tomography lymphography with intrapulmonary injection of iopamidol for sentinel lymph node localization. Invest Radiol; 2004 Jun;39(6):313-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computed tomography lymphography with intrapulmonary injection of iopamidol for sentinel lymph node localization.
  • PURPOSE: Experimental and clinical evaluation of the potential utility of indirect computed tomographic lymphography (CT-LG) with intrapulmonary injection of iopamidol for preoperative localization of sentinel lymph node station in non-small cell lung cancer.
  • METHODS: CT-LG with intrapulmonary injection of 0.5 mL of undiluted iopamidol was performed in 10 dogs using a multidetector-row CT unit, followed by postmortem examination of enhanced lymph nodes in 5 of these dogs.
  • The CT-LG with peritumoral injection of 1 mL of the contrast agent was also performed in 9 patients with non-small cell lung cancer without lymphadenopathy.
  • At surgery, enhanced lymph nodes were resected under CT-LG guide, followed by standard lymph node dissection with macroscopic and histologic examination.
  • A significant enhancement of lymph nodes was determined when CT attenuation value was increased with 30 Hounsfield units (HU) compared with precontrast images.
  • RESULTS: CT-LG visualized a total of 15 enhanced lymph nodes (on average, 1.5 nodes per animal) within 2 minutes after contrast injection in the 10 dogs, with average size of 6.7+/- 1.9 mm and average maximum CT attenuation of 149 +/- 41 HU.
  • All the 8 enhanced nodes in 5 dogs were found in the appropriate anatomic locations in postmortem examinations.
  • Without noticeable complications, CT-LG visualized 30 ipsilateral intrathoracic lymph nodes including 19 hilar/pulmonary and 11 mediastinal nodes in the 9 patients (on average, 2.2 hilar/pulmonary and 1.1 mediastinal nodes per patient) within 2 minutes after contrast injection, with average size of 4.7+/- 0.4 mm and average maximum CT attenuation of 134 +/- 52 HU.
  • At surgery, all these enhanced nodes could be accurately found and resected under CT-LG guidance.
  • Metastasis was not evident in either of these enhanced lymph nodes or the remaining distant nodes in all patients.
  • CONCLUSION: Quick and accurate localization of sentinel lymph node station on detailed underlying lung anatomy by using indirect CT-LG may be of value to guide selective lymph node dissection for minimally invasive surgery in non-small cell lung cancer.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / pathology. Contrast Media / administration & dosage. Iopamidol / administration & dosage. Lung Neoplasms / pathology. Lymphography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Animals. Dogs. Female. Humans. Injections. Lung. Lymph Node Excision. Male. Middle Aged. Preoperative Care

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15167097.001).
  • [ISSN] 0020-9996
  • [Journal-full-title] Investigative radiology
  • [ISO-abbreviation] Invest Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; JR13W81H44 / Iopamidol
  •  go-up   go-down


Advertisement
4. Kevorkov NN, Gorovits GA, Bakhmet'ev SA: [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes]. Ter Arkh; 2002;74(3):55-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes].
  • AIM: To examine the functional status of the immune system in patients with lung and intrathoracic lymph nodes sarcoidosis and to evaluate the efficiency of immunomodulation alone and in its inclusion in combined treatment of the disease.
  • [MeSH-major] Acetylmuramyl-Alanyl-Isoglutamine / analogs & derivatives. Acetylmuramyl-Alanyl-Isoglutamine / therapeutic use. Adjuvants, Immunologic / therapeutic use. Lymph Nodes / pathology. Sarcoidosis / drug therapy
  • [MeSH-minor] Adult. Drug Therapy, Combination. Glucocorticoids / adverse effects. Glucocorticoids / therapeutic use. Humans. Middle Aged. Oligopeptides / therapeutic use. Peptides / therapeutic use. Plant Preparations / therapeutic use. Recurrence. Sarcoidosis, Pulmonary / drug therapy. Sarcoidosis, Pulmonary / immunology. Thorax. Thymus Extracts / therapeutic use. Vitamins / therapeutic use

  • Genetic Alliance. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Sarcoidosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11980125.001).
  • [ISSN] 0040-3660
  • [Journal-full-title] Terapevticheskiĭ arkhiv
  • [ISO-abbreviation] Ter. Arkh.
  • [Language] rus
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] Russia
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Glucocorticoids; 0 / Oligopeptides; 0 / Peptides; 0 / Plant Preparations; 0 / Thymus Extracts; 0 / Vitamins; 0 / glikopin; 0 / thymohexin; 53678-77-6 / Acetylmuramyl-Alanyl-Isoglutamine; 89492-35-3 / T-activin
  •  go-up   go-down






Advertisement